189 related articles for article (PubMed ID: 36879169)
1. Inflammatory monocytes promote granuloma control of Yersinia infection.
Sorobetea D; Matsuda R; Peterson ST; Grayczyk JP; Rao I; Krespan E; Lanza M; Assenmacher CA; Mack M; Beiting DP; Radaelli E; Brodsky IE
Nat Microbiol; 2023 Apr; 8(4):666-678. PubMed ID: 36879169
[TBL] [Abstract][Full Text] [Related]
2. CCR2
Zhang Y; Khairallah C; Sheridan BS; van der Velden AWM; Bliska JB
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263104
[TBL] [Abstract][Full Text] [Related]
3. A TNF-IL-1 circuit controls Yersinia within intestinal pyogranulomas.
Matsuda R; Sorobetea D; Zhang J; Peterson ST; Grayczyk JP; Yost W; Apenes N; Kovalik ME; Herrmann B; O'Neill RJ; Bohrer AC; Lanza M; Assenmacher CA; Mayer-Barber KD; Shin S; Brodsky IE
J Exp Med; 2024 Mar; 221(3):. PubMed ID: 38363547
[TBL] [Abstract][Full Text] [Related]
4. Role of the Yersinia pseudotuberculosis Virulence Plasmid in Pathogen-Phagocyte Interactions in Mesenteric Lymph Nodes.
Bliska JB; Brodsky IE; Mecsas J
EcoSal Plus; 2021 Dec; 9(2):eESP00142021. PubMed ID: 34910573
[TBL] [Abstract][Full Text] [Related]
5. Cell type-specific effects of Yersinia pseudotuberculosis virulence effectors.
Fahlgren A; Westermark L; Akopyan K; Fällman M
Cell Microbiol; 2009 Dec; 11(12):1750-67. PubMed ID: 19681909
[TBL] [Abstract][Full Text] [Related]
6. Genome Scale Analysis Reveals IscR Directly and Indirectly Regulates Virulence Factor Genes in Pathogenic
Balderas D; Mettert E; Lam HN; Banerjee R; Gverzdys T; Alvarez P; Saarunya G; Tanner N; Zoubedi A; Wei Y; Kiley PJ; Auerbuch V
mBio; 2021 Jun; 12(3):e0063321. PubMed ID: 34060331
[TBL] [Abstract][Full Text] [Related]
7. A TNF-IL-1 circuit controls
Matsuda R; Sorobetea D; Zhang J; Peterson ST; Grayczyk JP; Herrmann B; Yost W; O'Neill R; Bohrer AC; Lanza M; Assenmacher CA; Mayer-Barber KD; Shin S; Brodsky IE
bioRxiv; 2023 Apr; ():. PubMed ID: 37197029
[TBL] [Abstract][Full Text] [Related]
8. Yersinia pseudotuberculosis YopH targets SKAP2-dependent and independent signaling pathways to block neutrophil antimicrobial mechanisms during infection.
Shaban L; Nguyen GT; Mecsas-Faxon BD; Swanson KD; Tan S; Mecsas J
PLoS Pathog; 2020 May; 16(5):e1008576. PubMed ID: 32392230
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the plasmid composition of Yersinia pseudotuberculosis strains and its use for typing pseudotuberculosis pathogens].
Shubin FN; Gintsburg AL; Kitaev VM; Ianishevskiĭ NV; Zenkova ZG
Mol Gen Mikrobiol Virusol; 1989 Jun; (6):20-5. PubMed ID: 2682219
[TBL] [Abstract][Full Text] [Related]
10. Interaction between the Yersinia protein tyrosine phosphatase YopH and eukaryotic Cas/Fyb is an important virulence mechanism.
Deleuil F; Mogemark L; Francis MS; Wolf-Watz H; Fällman M
Cell Microbiol; 2003 Jan; 5(1):53-64. PubMed ID: 12542470
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.
McPhee JB; Mena P; Zhang Y; Bliska JB
Infect Immun; 2012 Jul; 80(7):2519-27. PubMed ID: 22547545
[TBL] [Abstract][Full Text] [Related]
12. The role of Yersinia enterocolitica and Yersinia pseudotuberculosis in granulomatous appendicitis: a histologic and molecular study.
Lamps LW; Madhusudhan KT; Greenson JK; Pierce RH; Massoll NA; Chiles MC; Dean PJ; Scott MA
Am J Surg Pathol; 2001 Apr; 25(4):508-15. PubMed ID: 11257626
[TBL] [Abstract][Full Text] [Related]
13. Hereditary Hemochromatosis Predisposes Mice to Yersinia pseudotuberculosis Infection Even in the Absence of the Type III Secretion System.
Miller HK; Schwiesow L; Au-Yeung W; Auerbuch V
Front Cell Infect Microbiol; 2016; 6():69. PubMed ID: 27446816
[TBL] [Abstract][Full Text] [Related]
14. Two substrate-targeting sites in the Yersinia protein tyrosine phosphatase co-operate to promote bacterial virulence.
Ivanov MI; Stuckey JA; Schubert HL; Saper MA; Bliska JB
Mol Microbiol; 2005 Mar; 55(5):1346-56. PubMed ID: 15720545
[TBL] [Abstract][Full Text] [Related]
15. Inheritance of the lysozyme inhibitor Ivy was an important evolutionary step by Yersinia pestis to avoid the host innate immune response.
Derbise A; Pierre F; Merchez M; Pradel E; Laouami S; Ricard I; Sirard JC; Fritz J; Lemaître N; Akinbi H; Boneca IG; Sebbane F
J Infect Dis; 2013 May; 207(10):1535-43. PubMed ID: 23402825
[TBL] [Abstract][Full Text] [Related]
16. Identification of specific sequence motif of YopN of Yersinia pseudotuberculosis required for systemic infection.
Bamyaci S; Nordfelth R; Forsberg Å
Virulence; 2019 Dec; 10(1):10-25. PubMed ID: 30488778
[TBL] [Abstract][Full Text] [Related]
17. Yersinia pseudotuberculosis efficiently escapes polymorphonuclear neutrophils during early infection.
Westermark L; Fahlgren A; Fällman M
Infect Immun; 2014 Mar; 82(3):1181-91. PubMed ID: 24379291
[TBL] [Abstract][Full Text] [Related]
18. Yersinia pseudotuberculosis disrupts intestinal barrier integrity through hematopoietic TLR-2 signaling.
Jung C; Meinzer U; Montcuquet N; Thachil E; Château D; Thiébaut R; Roy M; Alnabhani Z; Berrebi D; Dussaillant M; Pedruzzi E; Thenet S; Cerf-Bensussan N; Hugot JP; Barreau F
J Clin Invest; 2012 Jun; 122(6):2239-51. PubMed ID: 22565313
[TBL] [Abstract][Full Text] [Related]
19. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
Fisher ML; Castillo C; Mecsas J
Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
[TBL] [Abstract][Full Text] [Related]
20. The cytotoxic necrotizing factor of Yersinia pseudotuberculosis (CNFY) enhances inflammation and Yop delivery during infection by activation of Rho GTPases.
Schweer J; Kulkarni D; Kochut A; Pezoldt J; Pisano F; Pils MC; Genth H; Huehn J; Dersch P
PLoS Pathog; 2013; 9(11):e1003746. PubMed ID: 24244167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
